✨ Medicines Notices
NEW ZEALAND GAZETTE, No. 95 — 20 OCTOBER 2016
In the notice with the above title, published in the New Zealand Gazette, 29 September 2016, Issue No. 86, Notice No. 2016-go5471, replace:
"The determination will appear in Inland Revenue’s Tax Information Bulletin, Vol. 28, No. 10, of November 2016"
with
"The determination will appear in Inland Revenue’s Tax Information Bulletin, Vol. 28, No. 10, of October 2016".
Dated this 14th day of October 2016.
JOHN TREZISE.
2016-go5911
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Clustran
Sumatriptan succinate 16.8mg/mL equivalent to sumatriptan 12mg/mL (6mg/0.5mL)
Solution for injection
Actavis New Zealand Limited
Sun Pharmaceutical Industries Limited, Halol, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Solifenacin Actavis
Solifenacin succinate 5mg
Film coated tablet
Actavis New Zealand Limited
Actavis ehf, Hafnarfjordur, Iceland
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Solifenacin Actavis
Solifenacin succinate 10mg
Film coated tablet
Actavis New Zealand Limited
Actavis ehf, Hafnarfjordur, Iceland
Dated this 14th day of October 2016.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go5917
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Ioscan
Amidotrizoic acid dihydrate 378.65mg/mL
Oral solution
Regional Health Limited
Surch Australia, Sydney, Australia
Tismor Health and Wellness Pty Limited, Sydney, Australia
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Penthrox
Methoxyflurane 99.9%w/w
Volatile liquid for inhalation
Douglas Pharmaceuticals Limited
Medical Developments International Limited, Melbourne, Australia
48
Next Page →
NZ Gazette 2016, No 95
✨ LLM interpretation of page content
💰 Correction to Tax Information Bulletin Notice
💰 Finance & Revenue14 October 2016
Correction, Tax Information Bulletin, Inland Revenue
- John Trezise
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare14 October 2016
Medicines, Distribution, Consent, Clustran, Solifenacin Actavis
- Sarah Reader, Acting Group Manager, Medsafe, Ministry of Health
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare14 October 2016
Medicines, Distribution, Consent, Ioscan, Penthrox
- Sarah Reader, Acting Group Manager, Medsafe, Ministry of Health